Table 1 The impact of obesity on T cell subsets in the peripheral blood and bone marrow of OA patients.

CD4:CD8 ratio

2.7 ± 0.8

0.7 ± 0.1

2.9 ± 0.6

1.4 ± 0.3

 % T_N

45.5 ± 6.6

25.8 ± 5.8

43.3 ± 3.8

31.4 ± 4.3

 % T_CM

34.3 ± 3.6

31 ± 5

40.9 ± 3.2

33.7 ± 2.7

 % T_EM

14.1 ± 4.3

38.9 ± 4.8

13.9 ± 1.8

32.3 ± 3.4

 % T_EMRA

5.4 ± 1.2

4.3 ± 1

3.3 ± 1.2

2.7 ± 0.4

 % CD28⁻

1.5 ± 0.6

1.7 ± 0.4

1.1 ± 0.4

1.3 ± 0.4

 % CD69⁺

0.2 ± 0.1

15.3 ± 1.9

0.4 ± 0.2

15.2 ± 2.5

 % T_reg

3 ± 0.4

3.3 ± 0.7

3.5 ± 0.9

3 ± 0.4

 % IFN-γ⁺

19.2 ± 3.4

31.7 ± 6

10.1 ± 1.9

21.2 ± 6.2

 % IL-4⁺

3.7 ± 1.1

3.4 ± 0.9

2.4 ± 0.7

1.6 ± 0.7

 % IL-2⁺

59.7 ± 5.1

47.4 ± 8.7

55.1 ± 5.7

32.5 ± 8.3

 % IL-10⁺

0.38 ± 0.06

1.6 ± 0.6

0.29 ± 0.05

1.7 ± 0.2

 % IL-17A⁺

0.34 ± 0.11

0.67 ± 0.32

0.77 ± 0.12

1.14 ± 0.16

 % IL-17A⁺ IFN-γ⁺

0.01 ± 0.004

0.14 ± 0.06

0.09 ± 0.05

0.39 ± 0.08

 % polyfunctional

10.9 ± 1.3

19.8 ± 4.2

6.3 ± 1.3

10.8 ± 6.6

 % T_N

14.8 ± 5.5

6.3 ± 0.9

12.3 ± 2.4

8.6 ± 1.3

 % T_CM

15.3 ± 2.6

12.3 ± 3.9

19.9 ± 3.9

14 ± 1.7

 % T_EM

37.2 ± 6.1

51.6 ± 2.4

38.2 ± 7.2

50.5 ± 3.9

 % T_EMRA

32.7 ± 4.5

29.7 ± 5

29.6 ± 4.6

26.9 ± 3.4

 % CD28⁻

46.7 ± 9.8

32.5 ± 4.1

43.2 ± 10.5

32.3 ± 6.1

 % CD28⁻ CD57⁺

28.1 ± 10.8

6.5 ± 3.1

33.5 ± 8.9

11.5 ± 4.9

 % CD69⁺

1.1 ± 0.3

44.4 ± 5.8

1.5 ± 0.3

52.1 ± 5.6

 % IFN-γ⁺

47.8 ± 10.4

54 ± 9.6

49.7 ± 9.5

64.2 ± 11.3

 % IL-2⁺

22.1 ± 6.6

21.4 ± 7.1

19.6 ± 5.5

22.1 ± 7.6

 % polyfunctional

13.9 ± 2.8

19.3 ± 4.3

11 ± 3.5

22.9 ± 1.6